Margaret Hamburg on the EMA at 20: An ever stronger bilateral partnership with the US FDA
This article was originally published in SRA
Executive Summary
The partnership between the US Food and Drug Administration and the European Medicines Agency is rightly very strong, but now a broader, global regulatory approach is needed to ensure the safety and effectiveness of pharmaceutical products worldwide, says Margaret Hamburg, the outgoing commissioner of the US agency.